XML 41 R25.htm IDEA: XBRL DOCUMENT v3.25.3

Nature of Business and Organization (Tables)

12 Months Ended

Jun. 30, 2025

Nature of Business and Organization [Abstract]

Schedule of Consolidated Financial Statements Reflect the Activities of the Company

The accompanying consolidated financial statements reflect the activities of the Company and each of the following entities:

Name of Entity		Principal Activities		Place and Date of Incorporation		Ownership
Regencell Bioscience Limited		Research and Development Day-to-day operations		Hong Kong, incorporated on May 12, 2015		100% owned by Regencell Bioscience Holdings Limited
Regencell Limited		Production and testing laboratory Research and Development		Hong Kong, incorporated on November 20, 2014		100% owned by Regencell Bioscience Holdings Limited
Regencell Bioscience Asia Limited		Research and Development		Hong Kong, incorporated on September 17, 2021 (Ceased business on December 31, 2023 and deregistered on November 1, 2024)		60% owned by Regencell Bioscience Limited
Regencell Bioscience North America Limited		Research and Development		BVI, incorporated on April 25, 2022		100% owned by Regencell Bioscience Holdings Limited

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration